A Phase 3 Trial of Upadacitinib for Giant-Cell Arteritis

Dr. Shuvro Roy talks with Dr. Daniel Blockmans about the efficacy and safety of upadacitinib as a treatment option for giant-cell arteritis. 

Read the related article in The New England Journal of Medicine. 

Disclosures can be found at Neurology.org.